Clinical Trials Browser

Carcinoma, Renal Cell × pazopanib × 30 days × Clear all

NCT01575548 2026-03-18

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Phase 3 Active not recruiting

129 enrolled 11 charts

Carcinoma, Renal Cell

NCT01684397 2026-02-27

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT02184416 2026-02-27

ADONIS

Carcinoma, Renal Cell